1,000
Participants
Start Date
April 12, 2023
Primary Completion Date
April 30, 2028
Study Completion Date
April 30, 2028
Pulmonary endarterectomy
Surgical removal of a chronic clot from the pulmonary artery
Balloon pulmonary angioplasty
Catheter-based intervention to dilate occluded pulmonary vessels through the insertion and inflation of a small balloon
Pulmonary hypertension (PH)-specific medication
Treatment with any PH-specific medication, i.e. endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, soluble guanylate cyclase stimulators, drugs acting on the prostanoid pathway and prostaglandin I2 receptor agonists
University Hospital Vienna, Vienna
University Hospitals Leuven, Leuven
Aarhus University Hospital, Aarhus
General University Hospital, Prague
National Heart Institute, Mexico City
Duke University, Durham
Pulmonary Hypertension Unit, Hospital 12 de Octubre, Madrid
Marmara University School of Medicine, Istanbul
University of Bologna, Bologna
Northwestern University, Evanston
Kerckhoff Clinic, Department of Thoracic Surgery, Bad Nauheim
UT Southwestern, Dallas
University of California San Diego, San Diego
China-Japan Friendship Hospital, Beijing
Shaio Clinic Foundation, Bogotá
National Heart Centre of Singapore, Singapore
Narayana Institute of Cardiac Science, Bangalore
Hospital Universitario Fundación Favaloro, Buenos Aires
Santa Casa, Porto Alegre
Toronto General Hospital, Toronto
Okayama Medical Center, Okayama
National Cerebral and Cardiovascular Center, Osaka
Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow
Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, European Health Center Otwock, Otwock
Royal Papworth Hospital, Cambridge
Collaborators (1)
Janssen Pharmaceuticals
INDUSTRY
International CTEPH Association
OTHER